国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

美國Dynavax Technologies 
流感疫苗 Dynavax技術(shù)公司是一家臨床階段的生物制藥公司，致力于發(fā)現和開(kāi)發(fā)新產(chǎn)品，以預防和治療感染性疾病。

Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious diseases. Our clinical-stage product candidates include:

Phase 3 HEPLISAV ? Hepatitis B Vaccine
Phase 1 Hepatitis C Therapy
Phase 1 Hepatitis B Therapy
In addition, we are developing a preclinical Universal Flu vaccine and programs partnered with pharmaceutical companies, including AstraZeneca and GlaxoSmithKline.

Our European subsidiary Rhein Biotech manufactures hepatitis B surface antigen for HEPLISAV. With 20 years in business, Rhein Biotech also provides integrated product development services to enable its partners to bring products to market.